Crossmark

Climate Change and the Switch from Pressurised Metered-Dose Inhalers to Dry Powder Inhalers: A Proportionate Balancing of Risk and Reward?

Published Online: 2026-03-12

Authors

Dissanayake, Sanjeeva https://orcid.org/0000-0002-4257-2141
Suggett, Jason

Kaplan, Alan
License Information

Text and Data Mining valid from 2026-03-12

Version of Record valid from 2026-03-12
More Information

Article History

Received: 17 November 2025

Accepted: 24 February 2026

First Online: 12 March 2026

Declarations

:

: Jason Suggett is an employee of Trudell Medical International. Sanjeeva Dissanayake is a director of Certior Consulting. Alan Kaplan is a medical doctor with conflicts including being on the advisory board and/or speaker’s bureau for ALK, Amgen, AstraZeneca, GSK, Metapharm, Pfizer, Roche, Sanofi, Trudel, and Valeo. He received no compensation for authoring this article.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current